BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 236 filers reported holding BLUEBIRD BIO INC in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,593,000 | +66.5% | 81,067 | +56.9% | 0.01% | +60.0% |
| Q1 2021 | $1,557,000 | -19.0% | 51,658 | +16.3% | 0.01% | -28.6% |
| Q4 2020 | $1,923,000 | -23.9% | 44,434 | -5.1% | 0.01% | -30.0% |
| Q3 2020 | $2,526,000 | +4.2% | 46,819 | +17.8% | 0.01% | 0.0% |
| Q2 2020 | $2,425,000 | +26.3% | 39,731 | -4.9% | 0.01% | +11.1% |
| Q1 2020 | $1,920,000 | -47.6% | 41,777 | 0.0% | 0.01% | -35.7% |
| Q4 2019 | $3,666,000 | -7.4% | 41,777 | -3.1% | 0.01% | -6.7% |
| Q3 2019 | $3,957,000 | – | 43,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,964,000 | $59,215,000 | 1.36% |
| Birchview Capital, LP | 75,500 | $2,276,000 | 1.35% |
| Camber Capital Management LP | 1,000,000 | $30,150,000 | 1.04% |
| Sessa Capital IM, L.P. | 875,000 | $26,381,000 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $16,226,000 | 0.92% |
| Tarsadia Capital, LLC | 100,000 | $3,015,000 | 0.81% |
| Bullseye Asset Management LLC | 67,872 | $2,046,000 | 0.76% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,304,246 | $39,323,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 175,178 | $5,282,000 | 0.53% |
| Parametrica Management Ltd | 37,712 | $1,080,000 | 0.52% |